Vice President, Scientific Innovation, Oncology
Sylvaine is the Vice President, Oncology Scientific Innovation at Johnson & Johnson Innovation in California. In this role, she is responsible for creating and implementing an external innovation plan focused on developing an industry-leading portfolio of oncology investment opportunities on the West Coast. She has significant experience in the fields of cancer biology and metabolism, with more than 16 years in research and drug discovery in both pharma and biotech.
Most recently, Sylvaine served as Senior Director in the Global Business Development Group and Head of External Science & Partnering, US West for Sanofi where she managed the US West Team’s biotech deal flow in alignment with the Sanofi R&D therapeutic areas. In this role, she sourced, built and managed alliances with academic centers in the US West ecosystem. Previous roles include Director of Pharmacology at Arete Therapeutics and Senior Group Leader at Cytokinetics where she led programs in cancer pharmacology and translational oncology.
Sylvaine has a Ph.D. in Molecular Oncology from the Institut Gustave Roussy for Cancer Research in Villejuif France / University of Paris VII, France, and a Masters in Bioengineering, Major in Biochemistry from AgroParisTech (National Institute of Agronomy, Paris, France). She spent her post-doctoral years at the Gladstone Institutes/UCSF and additionally holds a Sanofi Business Master Certificate from the London Business School.